根据该协议,Karveer有权在印度将公司的COVID药物NV-CoV-2和NV-CoV-2-R商业化。为了实现商业化,Karveer已经进行了临床开发和评估,并为此在印度赞助了这两种药物。
蹊之美股生物医药2021-09-23 23:00
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Aethlon Medical (NASDAQ:AEMD) +33%
Onconova Therapeutics (NASDAQ:ONTX) +28%
Dynavax Technologies (NASDAQ:DVAX) +26%
Candel Therapeutics (NASDAQ:CADL) +18%
BioCardia ...查看全文
蹊之美股生物医药2021-07-29 21:10
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Infinity Pharmaceuticals (NASDAQ:INFI) +62%
Tilray (NASDAQ:TLRY) +25%
Grove (NASDAQ:GRVI)+20%
NeuroMetrix (NASDAQ:NURO) +2%
成纤维细胞生长因子3是一种在多种肿瘤类型,尤...查看全文
智通财经APP获悉,NanoViricides(NNVC.US)周四表示,该公司已经开始研发对抗猴痘病毒的药物。受此消息提振,截至发稿,NanoViricides周四美股盘前暴涨47.97%,报3.64美元。 NanoViricides是一家基于新型纳米药物平台开发高效抗病毒疗法... 网页链接
$NanoViricides, Inc. NEW(NNVC)$ DEF 14A - Other definitive proxy statements Filed: 2018-10-19 AccNo: 0001144204-18-054566 Size: 1 MB 网页链接
$NanoViricides, Inc. NEW(NNVC)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2018-10-12 AccNo: 0001144204-18-053665 Size: 10 MB 网页链接
$NanoViricides, Inc. NEW(NNVC)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2018-10-12 AccNo: 0001214659-18-006490 Size: 45 KB 网页链接
$NanoViricides, Inc. NEW(NNVC)$ NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Filed: 2018-09-28 AccNo: 0001144204-18-051597 Size: 19 KB 网页链接
$NanoViricides, Inc. NEW(NNVC)$ 8-K/A [Amend] - Current report Filed: 2018-09-12 AccNo: 0001144204-18-049074 Size: 44 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem 5.02: Departure of Directors or Certain O...
$NanoViricides, Inc. NEW(NNVC)$ 8-K - Current report Filed: 2018-07-23 AccNo: 0001144204-18-039366 Size: 208 KBItem 1.01: Entry into a Material Definitive AgreementItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: C...
$NanoViricides, Inc. NEW(NNVC)$ 8-K - Current report Filed: 2018-07-19 AccNo: 0001144204-18-038907 Size: 85 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$NanoViricides, Inc. NEW(NNVC)$ 8-K - Current report Filed: 2018-07-11 AccNo: 0001144204-18-037894 Size: 32 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem 5.02: Departure of Directors or Certain Officers; E...
$NanoViricides, Inc. NEW(NNVC)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-05-21 AccNo: 0001144204-18-030083 Size: 5 MB 网页链接
$NanoViricides, Inc. NEW(NNVC)$ NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB Filed: 2018-05-15 AccNo: 0001144204-18-028923 Size: 21 KB 网页链接